COVID vaccinesVaccine patent waiver: COVID stopper or innovation killer?
Five things to know about India's proposal, US support and China's chance to gain
An Indian policeman asks people who came for COVID-19 vaccine shots to leave due to exhausted supplies in Mumbai on May 3. © Reuters
AKANE OKUTSU and KIRAN SHARMA, Nikkei staff writers
TOKYO/NEW DELHI -- The U.S. earlier this month said it supports temporarily waiving intellectual property protections on COVID-19 vaccines. In doing so, President Joe Biden's administration threw serious weight behind a proposal brought to the World Trade Organization by India and South Africa.